ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

Four NCAB Appointments Announced, Including Durant, Fisher; White House Delays On Others

April 4, 1986

Letter to the Editor

March 21, 2003

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

First Panel Meeting On Centers Generates Possible Recommendations For Core Grant Guideline Changes

April 6, 1984

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996